1-(bis(4-fluorophenyl)methyl)piperazine has been researched along with perhexiline in 1 studies
*Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. [MeSH]
*Perhexiline: 2-(2,2-Dicyclohexylethyl)piperidine. Coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. [MeSH]
| Studies (1-(bis(4-fluorophenyl)methyl)piperazine) | Trials (1-(bis(4-fluorophenyl)methyl)piperazine) | Recent Studies (post-2010) (1-(bis(4-fluorophenyl)methyl)piperazine) | Studies (perhexiline) | Trials (perhexiline) | Recent Studies (post-2010) (perhexiline) |
|---|---|---|---|---|---|
| 10 | 0 | 7 | 572 | 92 | 83 |
| Protein | Taxonomy | 1-(bis(4-fluorophenyl)methyl)piperazine (IC50) | perhexiline (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 1.4852 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 4.064 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.2942 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 3.5919 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 1.0932 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 6.38 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.9408 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 2.7105 | |
| D | Rattus norvegicus (Norway rat) | 7.7625 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7625 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 3.1186 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7625 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.7625 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.2942 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 7.7625 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 7.7687 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 2.5992 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, K; Izawa, Y; Koyama, T; Sakamoto, E; Sakuma, Y; Uno, H; Yamanaka, Y | 1 |
1 other study(ies) available for 1-(bis(4-fluorophenyl)methyl)piperazine and perhexiline
| Article | Year |
|---|---|
Lipidosis of the dorsal root ganglia in rats treated with an almitrine metabolite.
Topics: Administration, Oral; Almitrine; Animals; Calcium Channel Blockers; Cells, Cultured; Chromatography, High Pressure Liquid; Endothelium, Vascular; Female; Fluorobenzenes; Ganglia, Spinal; Lysosomes; Macrophages, Peritoneal; Microscopy, Electron; Neurons, Afferent; Perhexiline; Piperazines; Rats; Rats, Sprague-Dawley; Respiratory System Agents; Schwann Cells; Specific Pathogen-Free Organisms; Structure-Activity Relationship | 1995 |